Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjeev Kumar Mendiratta

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Critical Reviews in Therapeutic Drug Carrier Systems|November 26, 2003
Recent progress in polymeric gene delivery systemsKhursheed Anwer, B G Rhee, Sanjeev Kumar Mendiratta
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 24, 2021
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label studyShashi Bhushan B L, Sunil Wanve, Parshottam Koradia, et al.
Viruses|December 28, 2021
ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 InfectionPragya D Yadav, Sanjeev Kumar Mendiratta, Sreelekshmy Mohandas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Reply to Agrawal and KumarKevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2023
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in IndiaAnkit Patel, Niraj Bhatt, S S Prakash, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Critical Reviews in Therapeutic Drug Carrier Systems|November 26, 2003
Recent progress in polymeric gene delivery systemsKhursheed Anwer, B G Rhee, Sanjeev Kumar Mendiratta
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 24, 2021
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label studyShashi Bhushan B L, Sunil Wanve, Parshottam Koradia, et al.
Viruses|December 28, 2021
ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 InfectionPragya D Yadav, Sanjeev Kumar Mendiratta, Sreelekshmy Mohandas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Reply to Agrawal and KumarKevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2023
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in IndiaAnkit Patel, Niraj Bhatt, S S Prakash, et al.
Pageof 1